Filing Details
- Accession Number:
- 0001127602-21-016099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-10 13:00:00
- Reporting Period:
- 2021-05-07
- Accepted Time:
- 2021-05-10 17:18:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1351402 | A Troyen Brennan | One Cvs Drive Woonsocket RI 02895 | Evp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-07 | 9,477 | $84.00 | 144,697 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock (Restricted) | 4,805 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | $102.26 | 2016-04-01 | 2022-04-01 | 47,937 | 47,937 | Direct |
| Common Stock | Stock Option | $104.82 | 2017-04-01 | 2023-04-01 | 53,772 | 53,772 | Direct |
| Common Stock | Stock Option | $78.05 | 2018-04-03 | 2024-04-03 | 75,134 | 75,134 | Direct |
| Common Stock | Stock Option | $62.21 | 2019-04-01 | 2025-04-01 | 87,575 | 87,575 | Direct |
| Common Stock | Stock Option | $54.19 | 2020-04-01 | 2029-04-01 | 161,605 | 161,605 | Direct |
| Common Stock | Stock Option | $58.34 | 2021-04-01 | 2030-04-01 | 112,637 | 112,637 | Direct |
| Common Stock | Stock Option | $74.30 | 2022-04-01 | 2031-04-01 | 99,344 | 99,344 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-04-01 | 47,937 | 47,937 | Direct |
| 2023-04-01 | 53,772 | 53,772 | Direct |
| 2024-04-03 | 75,134 | 75,134 | Direct |
| 2025-04-01 | 87,575 | 87,575 | Direct |
| 2029-04-01 | 161,605 | 161,605 | Direct |
| 2030-04-01 | 112,637 | 112,637 | Direct |
| 2031-04-01 | 99,344 | 99,344 | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan.
- Option became exercisable in four equal annual installments, commencing 4/1/2016.
- Option became exercisable in four equal annual installments, commencing 4/1/2017.
- Option became exercisable in four equal annual installments, commencing 4/3/2018.
- Option became exercisable in four equal annual installments, commencing 4/1/2019.
- Option became exercisable in four equal annual installments, commencing 4/1/2020.
- The number of shares subject to the option were calculated using a 30-day average price.
- Options became exercisable in four equal annual installments, commencing 4/1/2021.
- Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
Billionaire Hedge Funds
